Adults with prediabetes experience a faster decline in kidney function than those with normal glucose, highlighting the need ...

Chronic Kidney Disease (CKD) is quietly rising as a global health crisis, and the latest research reveals just how serious ...

HOUSTON -- Two commonly used kidney function tests had a large degree of disagreement and were linked with serious health outcomes in patients with chronic kidney disease (CKD), according to a ...

CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition ...

A new testing protocol identifies patients whose chest pain is heart-related even though their main heart arteries look ...

In this video, Anjay Rastogi, MD, PhD, professor and Clinical Chief of Nephrology at the David Geffen School of Medicine at UCLA, discusses the screening process for chronic kidney disease.

CalciMedica (CALC) announced a poster presentation titled, “Store-Operated Calcium-Channel Inhibitor Auxora Improves Kidney Function Following Ischemia-Induced AKI in Rats” at the American Society of ...

"Trump’s executive order politicizes and weaponizes AI" and endangers American lives, explains Dr. Joel Bervell.

In patients with symptomatic multiple myeloma, renal impairment leading to acute kidney injury (AKI) is a common complication. Not only does AKI limit treatment and negatively impact quality of life, ...

Enrollment ongoing in Phase 2 KOURAGE trial of Auxora in acute kidney injury (AKI) with respiratory failure; data expected in 1H 2026 Positive discussions with FDA ...